Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Cui, Daxiang ^a   Zhang, Chunlei ^a   Liu, Bing ^a   Shu, Yi ^b   Du, Tong ^a   Shu, Dan ^b   Wang, Kan ^a   Dai, Fangping ^c   Liu, Yanlei ^a   Li, Chao ^a   Pan, Fei ^a   Yang, Yuming ^a   Ni, Jian ^a   Li, Hui ^b   Brand Saberi, Beate ^c   Guo, Peixuan ^b  

^a Shanghai Jiao Tong University   (China)

^b UNIVERSITY OF KENTUCKY   (United States)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARID4B PROTEIN, HUMAN; NANOPARTICLE; SMALL INTERFERING RNA; TUMOR ANTIGEN; TUMOR PROTEIN;

ANIMAL; ANTIBODY SPECIFICITY; APOPTOSIS; CELL PROLIFERATION; FEMALE; GENE SILENCING; GENE THERAPY; GENETICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; INVERTED REPEAT; METABOLISM; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; STOMACH NEOPLASMS; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTIGENS, NEOPLASM; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENETIC THERAPY; HUMANS; INJECTIONS, INTRAVENOUS; INVERTED REPEAT SEQUENCES; MICE, NUDE; NANOPARTICLES; NEOPLASM PROTEINS; ORGAN SPECIFICITY; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TUMOR BURDEN;

EID: 84949038379     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10726     Document Type: Article

References (60)

1. Ferlay, J. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer. 127, 2893-2917 (2010).
2. Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69-90 (2011).
3. Takahashi, T., Saikawa, Y. & Kitagawa, Y. Gastric cancer: current status of diagnosis and treatment. Cancers (Basel). 5, 48-63 (2013).
4. Dicken, B. J. et al. Gastric adenocarcinoma: review and considerations for future directions. Annals of surgery. 241, 27-39 (2005).
5. Uemura, N. et al. Helicobacter pylori infection and the development of gastric cancer. New England Journal of Medicine. 345, 784-789 (2001).
6. Comis, R. L. & Carter, S. K. A review of chemotherapy in gastric cancer. Cancer. 34, 1576-1586 (1974).
7. Kuo, C. Y., Chao, Y. & Li, C. P. Update on treatment of gastric cancer. Journal of the Chinese Medical Association: JCMA. (2014).
8. Proserpio, I. et al. Multimodal treatment of gastric cancer. World journal of gastrointestinal surgery. 6, 55-58 (2014).
9. Zhang, D. & Fan, D. New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives. Future Oncol. 6, 527-537 (2010).
10. Cui, D. X. et al. A microarray-based gastric carcinoma prewarning system. World J Gastroenterol. 11, 1273-82 (2005).
11. Zhang, Y. X. et al. Identification of volatile biomarkers of gastric cancer cells and ultrasensitive electrochemical detection based on sensing interface of Au-Ag alloy coated MWCNTs. Theranostics. 4, 154-62 (2014).
12. Wang, K. et al. BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer. J Nanobiotechnol. 1, 9-23 (2011).
13. Ruan, J. et al. HER2 monoclonal antibody conjugated RNase-A-associated CdTe quantum dots for targeted imaging and therapy of gastric cancer. Biomaterials. 33,7093-7102 (2012).
14. He, M. et al. Dual phase-controlled synthesis of uniform lanthanide-doped NaGdF4 upconversion nanocrystals via an OA/ionic liquid two-phase system for in vivo dual-modality imaging. Advanced Functional Materials 21, 4470-4477 (2011).
15. Huang, P. et al. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photothermal therapy. Biomaterials. 32, 9796-9809 (2011).
16. Huang, P. et al. Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhancedfluorescence imaging and photodynamic therapy. Adv. Mater. 24, 5104-5110 (2012).
17. Zhou, Z. J. et al. Folic acid-conjugated silica capped gold nanoclusters for targeted fluorescence/X-ray computed tomography imaging. Journal of Nanobiotechnology. 11, 17 (2013).
18. Zhang, C. L. et al. Glutathione-capped fluorescent gold nanoclusters for dual-modal fluorescence/X-ray computed tomography imaging. J. Mater. Chem. B. 1, 5045-5053 (2013).
19. Yang, W., Raufi, A. & Klempner, S. J. Targeted therapy for gastric cancer: Molecular pathways and ongoing investigations. Biochimica et biophysica acta. - Reviews on Cancer 1846, 232-237 (2014).
20. Shen, M. et al. Multifunctional drug delivery system for targeting tumor and its acidic microenvironment. Journal of controlled release : official journal of the Controlled Release Society. 161, 884-892 (2012).
21. Pan, B. F. et al. Synthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systems. Nanotechnology. 20, 125101 (2009).
22. Qi, L. et al. Cell-Penetrating Magnetic Nanoparticles for Highly Efficient Delivery and Intracellular Imaging of siRNA. Biomacromolecules 13, 2723-2730 (2012).
23. Guo, P. et al. Engineering RNA for targeted siRNA delivery and medical application. Advanced Drug Delivery Reviews. 62, 650-666 (2010).
24. Yu, X. & Pishko, M. V. Nanoparticle-based biocompatible and targeted drug delivery: characterization and in vitro studies. Biomacromolecules. 12, 3205-3212 (2011).
25. Zhou, J., Shum, K. T., Burnett, J. C. & Rossi, J. J. Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges. Pharmaceuticals (Basel, Switzerland). 6, 85-107 (2013).
26. Guo, P. The emerging field of RNA nanotechnology. Nature nanotechnology. 5, 833-842 (2010).
27. Guo, P., Haque, F., Hallahan, B., Reif, R. & Li, H. Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology. Nucleic acid therapeutics. 22, 226-245 (2012).
28. Guo, P., Zhang, C., Chen, C., Garver, K. & Trottier, M. Inter-RNA interaction of phage phi29 pRNA to form a hexameric complex for viral DNA transportation. Molecular cell. 2, 149-155 (1998).
29. Shu, D., Moll, W. D., Deng, Z., Mao, C. & Guo, P. Bottom-up Assembly of RNA Arrays and Superstructures as Potential Parts in Nanotechnology. Nano letters. 4, 1717-1723 (2004).
30. Shu, Y. et al. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs. RNA (New York, N.Y.). 19, 767-777 (2013).
31. Shu, D., Shu, Y., Haque, F., Abdelmawla, S. & Guo, P. Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics. Nature nanotechnology. 6, 658-667 (2011).
32. Abdelmawla, S. et al. Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery. Molecular therapy : the journal of the American Society of Gene Therapy. 19, 1312-1322 (2011).
33. Zhang, H. et al. Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNA. RNA (New York, N.Y.). 19, 1226-1237 (2013).
34. Shu, Y., Shu, D., Haque, F. & Guo, P. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells. Nature protocols. 8, 1635-1659 (2013).
35. Haque, F. et al. Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano today. 7, 245-257 (2012).
36. Khisamutdinov, E. F., Jasinski, D. L. & Guo, P. RNA as a boiling-resistant anionic polymer material to build robust structures with defined shape and stoichiometry. ACS nano. 8, 4771-4781 (2014).
37. Kawasaki, A.M. et al. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. Journal of Medicinal Chemistry. 36, 831-841 (1993).
38. Teng, L., Xie, J., Teng, L. & Lee, R. J. Clinical translation of folate receptor-targeted therapeutics. Expert opinion on drug delivery. 9, 901-908 (2012).
39. Ly, A., Hoyt, L., Crowell, J. & Kim, Y. I. Folate and DNA methylation. Antioxidants & redox signaling. 17, 302-326 (2012).
40. Gao, W., Xiang, B., Meng, T. T., Liu, F. & Qi, X. R. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. Biomaterials. 34, 4137-4149 (2013).
41. Shi, J. et al. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Biomaterials. 34, 251-261 (2013).
42. Huang, P. et al. Folic acid-conjugated Silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials. 32, 9796-9809 (2011).
43. Li, Z. M. et al. Aptamer-conjugated dendrimer-modified quantum dots for cancer cell targeting and imaging. Materials Letter. 64, 375-378 (2010).
44. Wang, Z., Ruan, J. & Cui, D. X. Advances and Prospect of Nanotechnology in Stem Cells. Nanoscale Resarch Letters. 4, 593-605 (2009).
45. Song, H. et al. Anti-HIF-1 alpha antibody-conjugated pluronic triblock copolymers encapsulated with Paclitaxel for tumor targeting therapy. Biomaterials. 31, 2302-2312 (2010).
46. Huang, P. et al. Folic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy . Theranostics. 1, 240-250 (2011).
47. Chen, F. et al. The photoluminescence, drug delivery and imaging properties of multifunctional Eu3t/Gd3t dual-doped hydroxyapatite nanorods. Biomaterials. 32, 9031-9039 (2011).
48. Ma, J. B. et al. Folic Acid-Conjugated LaF3:Yb,Tm@SiO2 Nanoprobes for Targeting Dual-Modality Imaging of Upconversion Luminescence and X-ray Computed Tomography. Journal Physical Chemistry C. 116, 14062-14070 (2012).
49. Cui, D. et al. Characterization of BRCAA1 and its novel antigen epitope identification. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 13, 1136-1145 (2004).
50. Yang, H. et al. Effect of blocking BRCAA1 gene with siRNA on proliferation of MCF-7 cells and expression of Rb gene. Ch in J Cancer Biother. 13, 181-184 (2006).
51. Li, C. et al. BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymerengineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer. Nanoscale Res. Lett. 9, 244 (2014).
52. Chen, L. et al. Tumor-specific Expression of MicroRNA-26a Suppresses Human Hepatocellular Carcinoma Growth via Cyclindependent and -independent Pathways. Molecular Therapy. 19, 1521-1528 (2011).
53. Fu, H. L. et al. TET1 Exerts Its Tumor Suppressor Function by Interacting with p53-EZH2 Pathway in Gastric Cancer. J. Biomed. Nanotechnol. 10, 1217-1230 (2014).
54. Chen, J. et al. Differential Expression of Phospholipase C Epsilon 1 Is Associated with Chronic Atrophic Gastritis and Gastric Cancer. PLoS One. 7, 10 (2012).
55. Jasinski, D. L., Khisamutdinov, E. F., Lyubchenko, Y. L. & Guo, P. Physicochemically Tunable Polyfunctionalized RNA Square Architecture with Fluorogenic and Ribozymatic Properties. ACS Nano. 26, 7620-7629 (2014).
56. Khisamutdinov, E. F. et al. Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles. Nucleic Acids Res. 42, 9996-10004 (2014).
57. Rychahou, P. et al. Delivery of RNA Nanoparticles into Colorectal Cancer Metastases Following Systemic Administration. ACS Nano. 9, 1108-16 (2015).
58. Lee, T. J. et al. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model. Oncotarget. In press (2015).
59. Li, H. et al. RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA are Resistant to I-125 and Cs-131 Radiation. Nucleic Acid Therapeutics. In press (2015).
60. Afonin, K. A. et al. Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine. Nature Protocol. 6, 2022-2034 (2011).